Clover Health Investments, Corp.
CLOV
$3.66
$0.205.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.34B | 1.32B | 1.30B | 1.27B | 1.24B |
| Total Other Revenue | 25.78M | 24.09M | 20.48M | 19.88M | 20.05M |
| Total Revenue | 1.37B | 1.34B | 1.32B | 1.29B | 1.26B |
| Cost of Revenue | 1.01B | 1.01B | 999.05M | 994.96M | 1.00B |
| Gross Profit | 364.34M | 329.01M | 317.65M | 290.75M | 258.47M |
| SG&A Expenses | 408.93M | 401.79M | 413.19M | 417.41M | 440.25M |
| Depreciation & Amortization | 1.33M | 1.66M | 1.88M | 2.55M | 2.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.42B | 1.42B | 1.41B | 1.41B | 1.45B |
| Operating Income | -45.93M | -74.44M | -97.42M | -129.22M | -184.29M |
| Income Before Tax | -46.27M | -92.73M | -117.56M | -153.62M | -210.15M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.27 | -92.73 | -117.56 | -153.62 | -210.15 |
| Earnings from Discontinued Operations | 3.26M | 1.34M | -6.14M | -6.31M | -3.21M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.01M | -91.39M | -123.70M | -159.93M | -213.36M |
| EBIT | -45.93M | -74.44M | -97.42M | -129.22M | -184.29M |
| EBITDA | -44.60M | -72.78M | -95.54M | -126.67M | -181.78M |
| EPS Basic | -0.09 | -0.19 | -0.26 | -0.33 | -0.44 |
| Normalized Basic EPS | -0.06 | -0.10 | -0.13 | -0.17 | -0.24 |
| EPS Diluted | -0.10 | -0.20 | -0.26 | -0.33 | -0.44 |
| Normalized Diluted EPS | -0.06 | -0.10 | -0.13 | -0.17 | -0.24 |
| Average Basic Shares Outstanding | 1.96B | 1.95B | 1.94B | 1.93B | 1.92B |
| Average Diluted Shares Outstanding | 1.96B | 1.95B | 1.94B | 1.93B | 1.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
